79
Participants
Start Date
July 19, 2022
Primary Completion Date
January 16, 2023
Study Completion Date
January 16, 2023
Avelumab
As provided in real world setting
National Hospital Organization Nagoya Medical Center, Nagoya
Asahi General Hospital, Asahi
Kurume University Hospital, Kurume
Ogaki Municipal Hospital, Ōgaki
St. Marianna University School of Medicine, Kawasaki
SHOWA University Fujigaoka Hospital, Yokohama
Nara Medical University Hospital, Kashihara
Osaka International Cancer Institute, Osaka
Kindai University Hospital, Sayama
Hamamatsu University Hospital, Hamamatsu
Akita University Hospital, Akita
National Hospital Organization Kyushu Cancer Center, Fukuoka
University Hospital Kyoto Prefectural University of Medicine IEC, Kyoto
University Hospital Kyoto Prefectural University of Medicine, Kyoto
Kyoto University Hospital, Kyoto
Toyama University Hospital, Toyama
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
INDUSTRY